HPS Pharmacies wish to advise that Echo Therapeutics are experiencing a supply interruption for Temgesic® sublingual tablets as follows:

Temgesic® Sublingual Tablets
Buprenorphine 200 microgram
ARTG 34091 

This short-term supply interruption affects both the 20-pack and 50-pack of sublingual tablets. Normal supplies are currently expected to resume by the end of March 2023.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Echo Therapeutics on 1300 848 328, or your pharmacist at HPS Pharmacies.

Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates